FDA Inspection 805292 — Pfizer Inc.

Pfizer Inc. — FEI 2416101

The FDA completed an inspection of Pfizer Inc. on Oct 15, 2012 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 11 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 15, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New York, NY (United States)

Citations

IDCFRDescription
672821 CFR 314.80(b)Failure to review ADE information
673021 CFR 314.80(b)Failure to develop written procedures
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
673521 CFR 314.80(c)(1)(ii)Failure to investigate serious, unexpected events
673621 CFR 314.80(c)(1)(ii)Submission of report follow-up
682321 CFR 314.80(c)Failure by applicant to report ADE
682521 CFR 314.80(c)(1)(iii)Non-applicant reports to applicant
682921 CFR 314.80(c)(2)Failure to report non-alert ADEs
683121 CFR 314.80(c)(2)Late submission of quarterly safety reports
683221 CFR 314.80(c)(2)Late submission of annual safety reports
684221 CFR 314.80(j)Failure to maintain records

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.